TY  - GEN
AU  - Moeder,Christopher B
AU  - Giltnane,Jennifer M
AU  - Harigopal,Malini
AU  - Molinaro,Annette
AU  - Robinson,Andrew
AU  - Gelmon,Karen
AU  - Huntsman,David
AU  - Camp,Robert L
AU  - Rimm,David L
TI  - Quantitative justification of the change from 10% to 30% for human epidermal growth factor receptor 2 scoring in the American Society of Clinical Oncology/College of American Pathologists guidelines: tumor heterogeneity in breast cancer and its implications for tissue microarray based assessment of outcome
SN  - 1527-7755
PY  - 2007///1213
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Biomarkers, Tumor
KW  - analysis
KW  - Breast Neoplasms
KW  - enzymology
KW  - Cohort Studies
KW  - Female
KW  - Humans
KW  - Immunohistochemistry
KW  - methods
KW  - Lymphatic Metastasis
KW  - Middle Aged
KW  - Protein Array Analysis
KW  - Receptor, ErbB-2
KW  - Receptors, Estrogen
KW  - Receptors, Progesterone
N1  - Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1200/JCO.2007.12.8033
ER  -